← Leaderboards
Nuria Tubau Juni
Biotherapeutics, Inc.
$2,445,560
Attributed
$2,445,560
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$2,445,560 · 3
By mechanism
R44$1,854,342 · 1
R43$591,218 · 2
Top collaborators
No co-investigators on record.
Most similar at Biotherapeutics, Inc.
Same institution · by research overlap
- Raquel Hontecillas$3,315,956
- Andrew Leber$4,071,154
- Ken Carter$148,288
Others in their field
Other Rising Stars on “Keratinocyte”
- Colton Joseph Lloyd · Sinopia Biosciences, Inc.$2,661,112
- Christine Guo Lian · Brigham And Women'S Hospital$2,178,309
- Kathy Shair · University Of Pittsburgh At Pittsburgh$1,815,953
- Brett Shook · George Washington University$1,340,668
- Martine Dunnwald · University Of Iowa$1,300,001
- Katarzyna Zwolinska · Louisiana State Univ Hsc Shreveport$1,277,427
Research focus
KeratinocyteOralImmuneInflammatory ResponseLesionMouse ModelFormulationIl17 GeneInflammatoryCellsDoseLeadDisease RemissionMarketingAccelerationComputer ModelsHistologicBiological Response Modifier TherapyCommercial ApplicationInflammation MediatorsAutoimmune DiseasesBiotechnologyAdrenal Cortex HormonesPersons
Grant awards (3)
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis$1,854,342
R44 · FY2025 · AR · contact PI
Development of Novel Topical Therapeutics for Psoriasis$295,924
R43 · FY2023 · AR · contact PI
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis$295,294
R43 · FY2023 · AR · contact PI